UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14351) 14351
Book Chapter (102) 102
Dissertation (51) 51
Magazine Article (12) 12
Publication (9) 9
Book / eBook (8) 8
Government Document (6) 6
Newsletter (6) 6
Web Resource (4) 4
Newspaper Article (3) 3
Streaming Video (3) 3
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12493) 12493
science & technology (10837) 10837
life sciences & biomedicine (10392) 10392
hematology (5122) 5122
oncology (4912) 4912
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (4712) 4712
leukemia, myelogenous, chronic, bcr-abl positive - genetics (4333) 4333
male (4134) 4134
fusion proteins, bcr-abl - genetics (3930) 3930
female (3904) 3904
biological and medical sciences (3697) 3697
chronic myeloid leukemia (3354) 3354
medical sciences (3346) 3346
imatinib mesylate (3328) 3328
adult (3274) 3274
middle aged (3268) 3268
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3092) 3092
benzamides (2695) 2695
animals (2646) 2646
leukemia (2569) 2569
hematologic and hematopoietic diseases (2331) 2331
antineoplastic agents - therapeutic use (2223) 2223
aged (2217) 2217
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (2209) 2209
pyrimidines - therapeutic use (2196) 2196
hemic and lymphatic diseases (1894) 1894
piperazines - therapeutic use (1863) 1863
protein kinase inhibitors - therapeutic use (1850) 1850
mice (1797) 1797
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (1794) 1794
fusion proteins, bcr-abl - metabolism (1710) 1710
imatinib (1481) 1481
abridged index medicus (1403) 1403
philadelphia chromosome (1375) 1375
treatment outcome (1364) 1364
bcr-abl (1363) 1363
mutation (1347) 1347
pyrimidines - pharmacology (1305) 1305
cancer (1281) 1281
protein-tyrosine kinases - antagonists & inhibitors (1275) 1275
leukemia, myelogenous, chronic, bcr-abl positive - therapy (1264) 1264
antineoplastic agents - pharmacology (1252) 1252
antineoplastic agents (1251) 1251
adolescent (1243) 1243
k562 cells (1209) 1209
cell biology (1152) 1152
biochemistry & molecular biology (1145) 1145
apoptosis (1138) 1138
piperazines - pharmacology (1108) 1108
research (1092) 1092
cml (1068) 1068
tyrosine (1059) 1059
cell line, tumor (1049) 1049
fusion proteins, bcr-abl - antagonists & inhibitors (987) 987
drug resistance, neoplasm (986) 986
protein kinase inhibitors - pharmacology (950) 950
tumor cells, cultured (943) 943
genetic aspects (941) 941
apoptosis - drug effects (939) 939
prognosis (933) 933
signal transduction (933) 933
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (919) 919
dasatinib (891) 891
pharmacology. drug treatments (878) 878
care and treatment (870) 870
kinases (852) 852
polymerase chain reaction (846) 846
gene expression (820) 820
bcr protein (813) 813
analysis (805) 805
molecular sequence data (782) 782
base sequence (774) 774
young adult (773) 773
aged, 80 and over (764) 764
proteins (751) 751
phosphorylation (732) 732
reverse transcriptase polymerase chain reaction (720) 720
myeloid leukemia (693) 693
stem cells (689) 689
precursor cell lymphoblastic leukemia-lymphoma - genetics (686) 686
hematology, oncology and palliative medicine (685) 685
chromosome aberrations (672) 672
pyrimidines - administration & dosage (659) 659
child (653) 653
pharmacology & pharmacy (643) 643
tumors (640) 640
chronic myelogenous leukemia (635) 635
genetics & heredity (633) 633
translocation, genetic (627) 627
rna, messenger - genetics (626) 626
pyrimidines - adverse effects (621) 621
leukemia, myelogenous, chronic, bcr-abl positive - enzymology (619) 619
immunology (611) 611
chemotherapy (604) 604
remission induction (596) 596
in situ hybridization, fluorescence (592) 592
cell line (591) 591
medicine, research & experimental (587) 587
drug resistance, neoplasm - genetics (586) 586
health aspects (586) 586
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13824) 13824
Chinese (526) 526
Japanese (232) 232
French (88) 88
Russian (65) 65
Spanish (60) 60
German (53) 53
Portuguese (43) 43
Polish (27) 27
Czech (16) 16
Hungarian (15) 15
Italian (14) 14
Ukrainian (12) 12
Danish (10) 10
Korean (6) 6
Norwegian (4) 4
Dutch (3) 3
Serbian (3) 3
Slovak (3) 3
Finnish (2) 2
Swedish (2) 2
Croatian (1) 1
Hebrew (1) 1
Persian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical journal, ISSN 0264-6021, 05/2015, Volume 467, Issue 3, pp. 365 - 386
Ubiquitin | Ubiquitination | Small molecule | Structure | Structure-based design | Assembly | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Protein Structure, Tertiary | Protein Subunits | Cullin Proteins - antagonists & inhibitors | Proteasome Inhibitors - pharmacology | Humans | Models, Molecular | Proteasome Inhibitors - chemistry | Drug Discovery - methods | Cullin Proteins - chemistry | Cullin Proteins - genetics | Drug Design | Protein Structure, Quaternary | Molecular Structure | Index Medicus | MEL26, maternal effect lethal 26 | small molecule | HECT, homologous with E6-associated protein C-terminus | DCAF, DDB1–Cul4A-associated factor | CPH, conserved within Cul7, PARC and HERC2 | CSA, Cockayne syndrome A | structure-based design | NAE, NEDD8-activating enzyme | Rbx1, RING-box protein 1 | PPI, protein–protein interaction | C, anaphase-promoting complex | SV5, simian virus 5 | Fbxw, F-box | Skp2, S-phase kinase-associated protein 2 | IAA, indole-3-acetic acid | Cpd, compound | Fbw | SMER3, small-molecule enhancer of rapamycin 3 | mTOR, mammalian target of rapamycin | HERC2, HECT domain- and RLD (regulator of chromosome condensation 1 protein-like domain) domain-containing E3 ubiquitin protein ligase 2 | IκB, inhibitor of NF-κB | UPS, ubiquitin–proteasome system | Nrf2, nuclear factor-erythroid 2-related factor 2 | Protac, proteolysis-targeting chimaeric molecule | WD repeat-containing protein | ZIM (zinc finger expressed in inflorescence) domain protein 1 | NF-κB, nuclear factor κB | leucine-rich motif-containing protein | CTD, C-terminal domain | Ub, ubiquitin | Vif, virion infectivity factor | NTD, N-terminal domain | GHR, growth hormone receptor | CRBN, cereblon | HIF-1α, hypoxia-inducible factor 1α | SH2, Src homology 2 | BP, β-propeller | UBL, ubiquitin-like protein | FP, fluorescence polarization | Cks1, cyclin-dependent protein kinase regulatory subunit 1 | CSN, COP9 (constitutive photomorphogenesis 9) signalosome complex | ITC, isothermal titration calorimetry | RING, really interesting new gene | Ubc12, ubiquitin-conjugating enzyme 12 | KLHL, Kelch-like protein | Review | VPRBP, Vpr-binding protein | SCF, Skp1–Cdc53–F-box Cdc4 | POZ, pox virus and zinc finger | JAZ1, jasmonate | Keap1, Kelch-like enoyl-CoA hydratase-associated protein 1 | PARC, p53-associated parkin-like cytoplasmic protein | DDB, damage-specific DNA-binding protein | JA-Ile, jasmonoyl-isoleucine | Fbxl, F-box | MATH, meprin and TRAF (tumour necrosis factor receptor-associated factor) homology | CRL, Cullin–RING E3 ubiquitin ligase | assembly | other domain-containing protein | COI1, coronatine-insensitive protein 1 | EloBC, ElonginB–ElonginC complex | broad complex | VHL, von Hippel–Lindau | Vpr, viral protein R | Aux, auxin | STAT, signal transducer and activator of transcription | CAND1, Cullin-associated NEDD8-dissociated protein 1 | Fbxo, F-box | TIR1, transport inhibitor response 1 | CBFβ, core binding factor β | BCR, BTB–Cul3–Rbx1 | structure | ubiquitin | cyclosome | SOCS, suppressor of cytokine signalling | NEDD, neural-precursor-cell-expressed developmentally down-regulated | BTB, bric-a-brac | APC | ubiquitination | Cdc, cell division cycle | Cul, Cullin | SPOP, speckle-type POZ protein | β-TrCP, β-transducin repeat-containing protein | tramtrack | ASB, ankyrin repeat and SOCS-box
Journal Article
International immunopharmacology, ISSN 1567-5769, 11/2013, Volume 17, Issue 3, pp. 638 - 650
Signaling | Receptors | Inflammation | Kinases | Neutrophils | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | Signal Transduction - immunology | Animals | Receptors, Cell Surface - immunology | Humans | Neutrophils - immunology | Selectins - immunology | Mycoses | Lectins | Fc receptors | Integrins | Index Medicus | FcR, Fc-receptor | GPI, glycosylphosphatidylinositol anchor | CLEC, C-type lectin | OSCAR, osteoclast-associated receptor | PKB, protein kinase B | DAG, diacyl-glycerol | Tyk2, tyrosine protein kinase 2 | VCAM-1, vascular cell adhesion molecule 1 | ICAM-1, intercellular adhesion molecule 1 | FADD, Fas-associated protein with death domain | IκB, inhibitor of NF-κB | GM-CSF, granulocyte | MyD88, myeloid differentiation protein 88 | TNF, tumor necrosis factor | LTβ, lymphotoxin β | TRADD, TNFR1-associated death domain protein | Abl, Abelson leukemia proto-oncogene | SLP-76, SH2 domain-containing leukocyte protein of 76 kDa | CALDAG-GEFI, calcium and DAG-regulated guanine nucleotide exchange factor I | IL, interleukin | Src, Rous sarcoma virus proto-oncogene | IRF, IFN regulatory factor | RIG, retinoic acid-inducible gene | PLC, phospholipase C | TCR, T-cell receptor | IKK, IκB kinase | ITAM, immunoreceptor tyrosine-based activation motif | CARD, caspase activation and recruitment domain | IP3, inositol-tris-phosphate | CHO, Chinese hamster ovary cells | MKK, MAP kinase kinase | fMLP, formly-Met-Leu-Phe | TRAF, TNF receptor-associated factor | MIP, macrophage inflammatory protein | Rac, Ras-related C3 botulinum toxin substrate | monocyte colony-stimulating factor | PIP3, phosphatidylinositol-3-phosphate | VLA-4, very late antigen 4 (α4β1 integrin) | PAF, platelet activating factor | STAT, signal transducer and activator of transcription | TAK, TGFβ-activated kinase 1 | Mac-1, macrophage antigen 1 (αMβ2 integrin) | FcRγ, Fc-receptor γ-chain | Asc, apoptosis-associated speck-like protein containing a CARD | cIAP, cellular inhibitor of apoptosis | BCR, B-cell receptor | Fgr, Gardner–Rasheed feline sarcoma proto-oncogene | VASP, vasodilator-stimulated phosphoprotein | Hck, hematopoietic cell kinase | TGFβ, transforming growth factor β | Rap, Ras-related protein | SHP-1, SH2 domain-containing protein tyrosine phosphatase 1 | Syk, spleen tyrosine kinase | GPCR, G protein-coupled receptor | G-CSF, granulocyte colony-stimulating factor | TREM, triggering receptor expressed on myeloid cells | DISC, death-inducing signaling complex | MDL-1, myeloid DAP12-associating lectin 1 | C3G, Crk SH3 domain-binding guanine nucleotide exchange factor (RapGEF1) | NF-κB, nuclear factor κB | ERM, ezrin-radixin-moesin | Epac1, exchange protein activated by cyclic AMP 1 | LTB4, leukotriene B4 | Mcl, macrophage C-type lectin | SAP130, Sin3A-associated protein of 130 kDa | SH2, Src-homology 2 domain | MAP kinase, mitogen-activated protein kinase | PSGL-1, P-selectin glycoprotein ligand | PI3K, phoshoinositide-3-kinase | ADAP, adhesion and degranulation promoting adapter protein (Fyb, SLAP-130) | NLRP3, NOD-like receptor family, pyrin domain containing 3 | MDA5, melanoma differentiation-associated protein 5 | TLR, Toll-like receptor | GRK, GPCR kinase | LAD, leukocyte adhesion deficiency | MAPKAP-kinase, MAP kinase-associated protein kinase | ZAP-70, ζ-chain-associated protein of 70 kDa | TRAIL, TNF-related apoptosis-inducing ligand | JNK, c-Jun N-terminal kinase | LFA-1, lymphocyte function-associated receptor 1 (αLβ2 integrin) | ROS, reactive oxygen species | RIP3, receptor-interacting serine-threonine protein kinase 3 | DAP12, DNAX activating protein 12 | IFN, interferon | PIR, paired immunoglobulin-like receptor | PKC, protein kinase C | PAK, p21-activated kinase | ESL-1, E-selectin ligand 1 | GAP, GTPase activating protein | ERK, extracellular signal-regulated kinase | SOCS, suppressor of cytokine signaling | JAK, Janus kinase | RANK, receptor activator of NF-κB | IRAK, IL-1 receptor-associated kinase | NOD, nucleotide-binding oligomerization domain containing protein | CEACAM3, carcinoembryonic antigen-related cell adhesion molecule 3 (CD66b)
Journal Article
Journal Article
Nature, ISSN 0028-0836, 08/2010, Volume 466, Issue 7307, pp. 765 - 768
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | RNA-Binding Proteins - genetics | Up-Regulation | Oncogene Proteins, Fusion - metabolism | Prognosis | Homeodomain Proteins - metabolism | Humans | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Nuclear Pore Complex Proteins - genetics | Cell Differentiation - genetics | RNA-Binding Proteins - biosynthesis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Nerve Tissue Proteins - biosynthesis | Membrane Proteins - metabolism | Blast Crisis - pathology | Signal Transduction | Membrane Proteins - genetics | Nuclear Pore Complex Proteins - metabolism | Mice, Inbred C57BL | Tumor Suppressor Protein p53 - metabolism | Receptor, Notch1 - metabolism | Nerve Tissue Proteins - genetics | Disease Progression | Homeodomain Proteins - genetics | Nerve Tissue Proteins - metabolism | Fusion Proteins, bcr-abl - genetics | Membrane Proteins - biosynthesis | Animals | Oncogene Proteins, Fusion - genetics | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Blast Crisis - genetics | Mice | Blast Crisis - metabolism | Fusion Proteins, bcr-abl - metabolism | RNA-Binding Proteins - metabolism | Myelocytic leukemia | Molecular genetics | Physiological aspects | Development and progression | Nonlymphoid leukemia | Cellular signal transduction | Genetic aspects | Research | Genetic regulation | Gene expression | Medical research | Stem cells | Chronic illnesses | Index Medicus
Journal Article